Dublin, Jan. 24, 2017 -- Research and Markets has announced the addition of the "Implantable Medical Devices Market Analysis and Trends - Product, Material - Forecast to 2025" report to their offering.
The Global Implantable Medical Devices Market is poised to grow at a CAGR of around 5.4% over the next decade to reach approximately $54.28 billion by 2025
Some of the prominent trends that the market is witnessing include 3D medical printing is expected to develop and find in several areas of medicine, Integrated circuits for next generation implantable medical devices , Growth of Biocompatible Silicone in implantable medical devices & Growth opportunities/Investment Opportunities.
Scope of the Report
- Based on Product the market is categorized into Dental Implants, Orthopedic Implants, Cardiovascular Implants, Breast implants, Intraocular lens , Orthobiologics, and Other implantable products.
- The Orthopedic Implants segment is further divided into Reconstructive Joint Replacement, Spinal Implants and Trauma fixation implants.
- Cardiovascular Implants segment is further categorized into Pacing Devices, Implantable Cardiac Pacemakers (ICPs), Cardiac Stents, Implantable Hemodynamic Monitors (IHMs), Implantable Heart Monitors and Drug-Eluting Stents.
- Other implants segment includes Gynecological Devices, Drug Implants, Otolaryngeal Implants, Cosmetic Implants, Gastroenterological Implants, Hormonal Implants and Urological Implants.
- Orthobiologics is further classified as Hyaluronic Acid, Bone Substitutes, Bone Growth Factors, Bone Cement and Tissue Implants.
Depending on the Material the market is segregated by Metals, Biologics, Ceramics and Polymers. - The Metal segment is further sub divided as Co-Cr Alloy, Stainless Steel, Titanium, Titanium Alloy and Zirconium.
- The Ceramics is fragmented as Zirconia ceramics (ZrO 2). The Polymers market is further as Biodegradable Polymers.
- The End User segment market is fragmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Clinics.
Companies Mentioned
- AQTIS Medical
- Abbott Laboratories
- Allergan Plc
- Arion Laboratories
- Bausch & Lomb Incorporated
- Bioha Laboratories
- Biomet Incorporated
- Edwards Lifesciences Corporation
- Establishment Labs
- Guangzhou Wanhe Plastic Material
- Hans Biomed
- Ivoclar Vivadent
- Johnson & Johnson
- Medtronic Incorporated
- Merck & Company Incorporated
- Nobel Biocare
- POLYTECH Health & Aesthetics
- St. Jude Medical Incorporated
- Straumann Group
- Stryker Corporation
- Synthes Incorporated
- Zimmer Holdings Incorporated
For more information about this report visit http://www.researchandmarkets.com/research/bpq4g4/implantable
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices


Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 



